Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers

• Published in: Biology direct Vol. 18; no. 1; p. 79
• Main Authors: Dou, Renjie, Kang, Shaobo, Yang, Huan, Zhang, Wanmei, Zhang, Yijing, Liu, Yuanyuan, Ping, Yanyan, Pang, Bo
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.11.2023; BioMed Central; BMC
• Subjects: Analysis; Breast cancer; Breast Neoplasms - genetics; Cancer; ceRNA network; Copy number; Critical components; Deregulation; Development and progression; Diagnosis; DNA Copy Number Variations; Driver miRNAs; Dysregulation; Female; Gene expression; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic aspects; Genomes; Genomics; Humans; Medical prognosis; MicroRNA; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; miRNA; Networks; Prognosis; Proteins; RNA, Long Noncoding - genetics; RNA, Long Noncoding - metabolism; Signal transduction; Somatic copy number alteration; Student's t-test; Transcriptome; Transcriptomes; China; Dysregulation; Prognosis; Somatic copy number alteration; ceRNA network; Driver miRNAs
• ISSN: 1745-6150; 1745-6150
• DOI: 10.1186/s13062-023-00438-x

MicroRNAs (miRNAs) play critical roles in cancer initiation and progression, which were critical components to maintain the dynamic balance of competing endogenous RNA (ceRNA) networks. Somatic copy number alterations (SCNAs) in the cancer genome could disturb the transcriptome level of miRNA to deregulate this balance. However, the driving effects of SCNAs of miRNAs were insufficiently understood. In this study, we proposed a method to dissect the functional roles of miRNAs under different copy number states and identify driver miRNAs by integrating miRNA SCNAs profile, miRNA-target relationships and expression profiles of miRNA, mRNA and lncRNA. Applying our method to 813 TCGA breast cancer (BRCA) samples, we identified 29 driver miRNAs whose SCNAs significantly and concordantly regulated their own expression levels and further inversely dysregulated expression levels of their targets or disturbed the miRNA-target networks they directly involved. Based on miRNA-target networks, we further constructed dynamic ceRNA networks driven by driver SCNAs of miRNAs and identified three different patterns of SCNA interference in the miRNA-mediated dynamic ceRNA networks. Survival analysis of driver miRNAs showed that high-level amplifications of four driver miRNAs (including has-miR-30d-3p, has-mir-30b-5p, has-miR-30d-5p and has-miR-151a-3p) in 8q24 characterized a new BRCA subtype with poor prognosis and contributed to the dysfunction of cancer-associated hallmarks in a complementary way. The SCNAs of driver miRNAs across different cancer types contributed to the cancer development by dysregulating different components of the same cancer hallmarks, suggesting the cancer specificity of driver miRNA. These results demonstrate the efficacy of our method in identifying driver miRNAs and elucidating their functional roles driven by endogenous SCNAs, which is useful for interpreting cancer genomes and pathogenic mechanisms.